United Therapeutics ROE 2012-2026 | UTHR

Current and historical return on equity (ROE) values for United Therapeutics (UTHR) over the last 10 years. Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Unlock Macrotrends Premium
40 years of data
Faster, ad-free pages
Unlimited data exports
Full-width charts
United Therapeutics ROE - Return on Equity Historical Data
Date TTM Net Income Shareholder's Equity Return on Equity
2026-06-30 $1.31B $6.50B 20.18%
2026-03-31 $1.29B $6.69B 19.25%
2025-12-31 $1.34B $6.92B 19.30%
2025-09-30 $1.27B $6.75B 18.83%
2025-06-30 $1.24B $6.63B 18.73%
2025-03-31 $1.21B $6.26B 19.32%
2024-12-31 $1.20B $5.90B 20.27%
2024-09-30 $1.11B $5.78B 19.22%
2024-06-30 $1.07B $5.68B 18.83%
2024-03-31 $1.05B $5.61B 18.73%
2023-12-31 $0.99B $5.56B 17.72%
2023-09-30 $0.90B $5.26B 17.11%
2023-06-30 $0.87B $4.97B 17.51%
2023-03-31 $0.73B $4.70B 15.49%
2022-12-31 $0.73B $4.46B 16.29%
2022-09-30 $0.71B $4.25B 16.62%
2022-06-30 $0.63B $4.07B 15.50%
2022-03-31 $0.69B $3.90B 17.64%
2021-12-31 $0.48B $3.72B 12.80%
2021-09-30 $0.46B $3.58B 12.94%
2021-06-30 $0.47B $3.44B 13.69%
2021-03-31 $0.41B $3.30B 12.26%
2020-12-31 $0.52B $3.18B 16.19%
2020-09-30 $0.47B $3.03B 15.50%
2020-06-30 $0.43B $2.89B 14.91%
2020-03-31 $0.53B $2.75B 19.19%
2019-12-31 $-0.11B $2.59B -4.05%
2019-09-30 $-0.09B $2.60B -3.58%
2019-06-30 $-0.12B $2.59B -4.56%
2019-03-31 $-0.15B $2.59B -5.79%
2018-12-31 $0.59B $2.60B 22.66%
2018-09-30 $0.54B $2.43B 22.36%
2018-06-30 $0.71B $2.28B 31.32%
2018-03-31 $0.48B $2.08B 23.28%
2017-12-31 $0.42B $2.00B 20.87%
2017-09-30 $0.51B $1.94B 26.23%
2017-06-30 $0.40B $1.88B 20.98%
2017-03-31 $0.66B $1.89B 34.76%
2016-12-31 $0.71B $1.80B 39.62%
2016-09-30 $0.71B $1.74B 40.83%
2016-06-30 $1.01B $1.64B 61.52%
2016-03-31 $0.90B $1.45B 62.26%
2015-12-31 $0.65B $1.30B 50.19%
2015-09-30 $0.66B $1.21B 54.70%
2015-06-30 $0.17B $1.14B 15.20%
2015-03-31 $0.19B $1.17B 15.87%
2014-12-31 $0.34B $1.23B 27.77%
2014-09-30 $0.20B $1.23B 15.82%
2014-06-30 $0.28B $1.25B 22.60%
2014-03-31 $0.25B $1.25B 20.08%
2013-12-31 $0.18B $1.21B 14.48%
2013-09-30 $0.29B $1.17B 24.72%
2013-06-30 $0.30B $1.12B 27.17%
2013-03-31 $0.30B $1.08B 27.40%
2012-12-31 $0.30B $1.05B 29.09%
2012-09-30 $0.26B $1.01B 26.11%
2012-06-30 $0.27B $1.02B 26.55%
2012-03-31 $0.27B $1.02B 26.80%
2011-12-31 $0.22B $0.99B 21.92%
2011-09-30 $0.18B $0.97B 18.90%
2011-06-30 $0.14B $0.91B 15.34%
2011-03-31 $0.10B $0.86B 12.12%
2010-12-31 $0.11B $0.81B 13.23%
2010-09-30 $0.09B $0.75B 12.52%
2010-06-30 $0.07B $0.70B 9.42%
2010-03-31 $0.03B $0.66B 3.96%
2009-12-31 $0.02B $0.62B 3.23%
2009-09-30 $-0.06B $0.59B -9.93%
2009-06-30 $-0.06B $0.54B -11.13%
2009-03-31 $-0.05B $0.48B -9.61%
2008-12-31 $-0.05B $0.42B -11.79%
2008-09-30 $0.03B $0.35B 7.69%
2008-06-30 $0.03B $0.30B 10.37%
2008-03-31 $0.03B $0.25B 9.88%
2007-12-31 $0.01B $0.21B 5.73%
2007-09-30 $0.07B $0.19B 39.68%
2007-06-30 $0.07B $0.20B 33.09%
2007-03-31 $0.07B $0.23B 29.65%
2006-12-31 $0.07B $0.27B 27.79%
2006-09-30 $0.05B $0.28B 16.56%
2006-06-30 $0.06B $0.28B 20.04%
2006-03-31 $0.06B $0.25B 23.25%
2005-12-31 $0.07B $0.23B 27.87%
2005-09-30 $0.04B $0.21B 20.24%
2005-06-30 $0.03B $0.20B 16.69%
2005-03-31 $0.03B $0.19B 13.42%
2004-12-31 $0.02B $0.18B 8.49%
2004-09-30 $0.01B $0.17B 2.93%
2004-06-30 $0.00B $0.17B -1.19%
2004-03-31 $-0.01B $0.17B -4.76%
2003-12-31 $-0.01B $0.17B -5.33%
2003-09-30 $-0.01B $0.17B -5.30%
2003-06-30 $-0.02B $0.17B -11.71%
2003-03-31 $-0.02B $0.18B -12.00%
2002-12-31 $-0.02B $0.18B -13.28%
2002-09-30 $-0.03B $0.19B -14.99%
2002-06-30 $-0.03B $0.19B -13.38%
2002-03-31 $-0.03B $0.20B -16.89%
2001-12-31 $-0.04B $0.21B -17.64%
2001-09-30 $-0.06B $0.22B -28.25%
2001-06-30 $-0.06B $0.23B -25.74%
2001-03-31 $-0.08B $0.21B -37.65%
2000-12-31 $-0.08B $0.18B -42.40%
2000-09-30 $-0.05B $0.13B -39.55%
2000-06-30 $-0.05B $0.09B -59.09%
2000-03-31 $-0.03B $0.07B -39.32%
1999-12-31 $-0.03B $0.04B -77.19%
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $21.460B $3.183B
United Therapeutics Corporation markets four medicines in the United States to treat pulmonary arterial hypertension (PAH): Remodulin, an injectable formulation of treprostinil, Orenitram, an oral version of treprostinil, Tyvaso, an inhaled version of treprostinil, and Adcirca (tadalafil; also sold by Eli Lilly as Cialis for erectile dysfunction) tablets.
Stock Name Country Market Cap PE Ratio
Chugai Pharmaceutical (CHGCY) Japan $68.396B 22.59
Takeda Pharmaceutical (TAK) Japan $59.919B 11.13
UCB SA (UCBJY) Belgium $45.739B 0.00
Otsuka Holdings, - (OTSKY) Japan $39.680B 14.84
BeOne Medicines - (ONC) Switzerland $38.041B 61.00
Sandoz Group AG (SDZNY) Switzerland $35.464B 0.00
Daiichi Sankyo, - (DSNKY) Japan $34.072B 21.27
Zoetis (ZTS) United States $30.343B 11.16
Astellas Pharma (ALPMY) Japan $26.892B 8.90
Merck (MKKGY) Germany $19.487B 15.54
Shionogi (SGIOY) Japan $15.947B 9.37
IPSEN (IPSEY) France $15.395B 0.00
Neurocrine Biosciences (NBIX) United States $15.249B 20.72
Summit Therapeutics (SMMT) United States $13.881B 0.00
Orion OYJ (ORINY) Finland $12.984B 18.93
Madrigal Pharmaceuticals (MDGL) United States $12.089B 0.00
Corcept Therapeutics (CORT) United States $11.979B 263.86
Recordati Industria Chimica E Farmaceutica S.P.A (RCDTF) Italy $11.965B 15.26
Crinetics Pharmaceuticals (CRNX) United States $9.013B 0.00
Eisai (ESAIY) $8.924B 0.00
Ionis Pharmaceuticals (IONS) United States $7.852B 0.00
Ono Pharmaceutical (OPHLF) Japan $7.049B 13.27
Stevanato Group S.p.A (STVN) Italy $6.523B 32.64
Centessa Pharmaceuticals (CNTA) United Kingdom $6.267B 0.00
Oruka Therapeutics (ORKA) United States $6.105B 0.00
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $5.317B 19.36
Grifols, S.A (GRFS) Spain $5.009B 0.00
Definium Therapeutics (DFTX) United States $4.947B 0.00
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $4.923B 0.00
Relay Therapeutics (RLAY) United States $4.157B 0.00
Indivior Pharmaceuticals (INDV) United States $4.039B 9.38
Enliven Therapeutics (ELVN) United States $3.910B 0.00
Catalyst Pharmaceuticals (CPRX) United States $3.855B 11.93
Amylyx Pharmaceuticals (AMLX) United States $3.694B 0.00
Dyne Therapeutics (DYN) United States $3.343B 0.00
Hypermarcas (HYPMY) Brazil $3.203B 9.10
Soleno Therapeutics (SLNO) United States $2.717B 228.83
NewAmsterdam Pharma (NAMS) Netherlands $2.529B 0.00
Guardian Pharmacy Services (GRDN) United States $2.390B 45.28
Nektar Therapeutics (NKTR) United States $2.275B 0.00
Ocular Therapeutix (OCUL) United States $2.238B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $2.146B 15.81
Avadel Pharmaceuticals (AVDL) Ireland $2.113B 0.00
BioCryst Pharmaceuticals (BCRX) United States $2.085B 5.63
Xencor (XNCR) United States $1.766B 0.00
KARDIGAN INC (KARD) United States $1.735B 0.00
Xeris Biopharma Holdings (XERS) United States $1.366B 107.00
Harrow (HROW) United States $1.269B 0.00
Seaport Therapeutics (SPTX) United States $1.229B 0.00
Aktis Oncology (AKTS) United States $1.204B 0.00
Cronos Group (CRON) Canada $1.179B 29.09
Bioventus (BVS) United States $1.093B 17.10
Savara (SVRA) United States $1.081B 0.00
KalVista Pharmaceuticals (KALV) United States $0.993B 0.00
Cybin (HELP) Canada $0.992B 0.00
Theravance Biopharma (TBPH) United States $0.885B 0.00
Avalo Therapeutics (AVTX) United States $0.862B 0.00
Ardelyx (ARDX) United States $0.847B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.821B 11.32
Esperion Therapeutics (ESPR) United States $0.819B 0.00
Aclaris Therapeutics (ACRS) United States $0.773B 0.00
Achieve Life Sciences (ACHV) Canada $0.753B 0.00
4D Molecular Therapeutics (FDMT) United States $0.753B 0.00
Silence Therapeutics (SLN) United Kingdom $0.750B 0.00
Apnimed (APMD) $0.711B 0.00
Collegium Pharmaceutical (COLL) United States $0.711B 3.13
Zevra Therapeutics (ZVRA) United States $0.692B 7.37
Ironwood Pharmaceuticals (IRWD) United States $0.671B 5.21
OmniAb (OABI) United States $0.630B 0.00
Altimmune (ALT) United States $0.628B 0.00
Aquestive Therapeutics (AQST) United States $0.604B 0.00
Evotec AG (EVO) Germany $0.580B 0.00
ProKidney (PROK) United States $0.526B 0.00
Indaptus Therapeutics (INDP) United States $0.485B 0.00
Relmada Therapeutics (RLMD) United States $0.474B 0.00
ARS Pharmaceuticals (SPRY) United States $0.423B 0.00
Larimar Therapeutics (LRMR) United States $0.406B 0.00
Prelude Therapeutics (PRLD) United States $0.361B 0.00
Century Therapeutics (IPSC) United States $0.359B 0.00
Lexeo Therapeutics (LXEO) United States $0.339B 0.00
Inhibikase Therapeutics (IKT) United States $0.322B 0.00
Avita Medical (RCEL) United States $0.314B 0.00
Pyxis Oncology (PYXS) United States $0.278B 0.00
USANA Health Sciences (USNA) United States $0.275B 15.05
Elite Pharmaceuticals (ELTP) United States $0.268B 12.44
Lyell Immunopharma (LYEL) United States $0.267B 0.00
Akebia Therapeutics (AKBA) United States $0.250B 0.00
Galectin Therapeutics (GALT) United States $0.246B 0.00
Nature's Sunshine Products (NATR) United States $0.230B 11.17
AleAnna (ANNA) United States $0.226B 17.84
Protara Therapeutics (TARA) United States $0.222B 0.00
Cardiol Therapeutics (CRDL) Canada $0.215B 0.00
Siga Technologies (SIGA) United States $0.214B 0.00
Journey Medical (DERM) United States $0.208B 0.00
Profound Medical (PROF) Canada $0.208B 0.00
Korro Bio (KRRO) United States $0.207B 0.00
Surrozen (SRZN) United States $0.206B 0.00
Tonix Pharmaceuticals Holding (TNXP) United States $0.199B 0.00
Organogenesis (ORGO) United States $0.188B 0.00
Minerva Neurosciences (NERV) United States $0.183B 0.00
MediWound (MDWD) Israel $0.173B 0.00
Atrium Therapeutics (RNA) United States $0.173B 0.00
NRx Pharmaceuticals (NRXP) United States $0.147B 0.00
Innate Pharma SA (IPHYF) France $0.138B 0.00
Unicycive Therapeutics (UNCY) United States $0.131B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.129B 0.00
VAXART, INC (VXRT) United States $0.117B 3.00
Assertio Holdings (ASRT) United States $0.116B 0.00
Rafael Holdings (RFL) United States $0.111B 0.00
Vivani Medical (VANI) United States $0.111B 0.00
Allergy Therapeutics (AGYTF) United Kingdom $0.103B 0.00
Cassava Sciences (SAVA) United States $0.101B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.099B 0.00
PolyPid (PYPD) Israel $0.098B 0.00
HST Global (HSTC) United States $0.092B 0.00
ElectroCore (ECOR) United States $0.091B 0.00
Fractyl Health (GUTS) United States $0.090B 0.00
Nutriband (NTRB) United States $0.083B 0.00
Aldeyra Therapeutics (ALDX) United States $0.083B 0.00
Telomir Pharmaceuticals (TELO) United States $0.080B 0.00
Verrica Pharmaceuticals (VRCA) United States $0.079B 0.00
Acrivon Therapeutics (ACRV) United States $0.078B 0.00
Gain Therapeutics (GANX) United States $0.075B 0.00
PMV Pharmaceuticals (PMVP) United States $0.073B 0.00
Champions Oncology (CSBR) United States $0.066B 0.00
Talphera (TLPH) United States $0.062B 0.00
Nuo Therapeutics (AURX) $0.061B 0.00
Heron Therapeutics (HRTX) United States $0.060B 0.00
Dominari Holdings (DOMH) United States $0.053B 0.00
Veraxa Biotech AG (VRXA) United States $0.048B 0.00
SCYNEXIS (SCYX) United States $0.044B 0.00
Incannex Healthcare (IXHL) Australia $0.041B 0.00
FibroGen (FGEN) United States $0.039B 0.00
Lite Strategy (LITS) United States $0.037B 0.00
Mural Oncology (MURA) Ireland $0.035B 0.00
Karyopharm Therapeutics (KPTI) United States $0.035B 0.00
Context Therapeutics (CNTX) United States $0.033B 0.00
Optimi Health (OPTH) Canada $0.029B 0.00
Cosmos Health (COSM) United States $0.028B 0.00
TransCode Therapeutics (RNAZ) United States $0.027B 0.00
Plus Therapeutics (PSTV) United States $0.027B 0.00
TherapeuticsMD (TXMD) United States $0.025B 0.00
Universe Pharmaceuticals INC (UPC) China $0.022B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.020B 0.00
VYNE Therapeutics (VYNE) United States $0.019B 0.00
Lipocine (LPCN) United States $0.018B 0.00
Klotho Neurosciences (KLTO) United States $0.016B 0.00
Mannatech (MTEX) United States $0.016B 0.00
Enlivex (ENLV) Israel $0.015B 0.00
Citius Pharmaceuticals (CTXR) United States $0.015B 0.00
BioVie (BIVI) United States $0.015B 0.00
Iterum Therapeutics (ITRM) Ireland $0.015B 0.00
Vyome Holdings (HIND) United States $0.014B 0.00
Quoin Pharmaceuticals (QNRX) United States $0.014B 0.00
Scienture Holdings (SCNX) United States $0.014B 0.00
Tempest Therapeutics (TPST) United States $0.012B 0.00
Natural Alternatives (NAII) United States $0.012B 0.00
BioLineRx (BLRX) Israel $0.012B 0.00
Phio Pharmaceuticals (PHIO) United States $0.012B 0.00
Kiora Pharmaceuticals (KPRX) United States $0.012B 0.00
CASI Pharmaceuticals (CASI) China $0.010B 0.00
Xenetic Biosciences (XBIO) United States $0.010B 0.00
Mangoceuticals (MGRX) United States $0.009B 0.00
Wellgistics Health (WGRX) United States $0.009B 0.00
Traws Pharma (TRAW) United States $0.008B 0.00
Inotiv (NOTV) United States $0.008B 0.00
Biomerica (BMRA) United States $0.007B 0.00
Curanex Pharmaceuticals Inc (CURX) United States $0.007B 0.00
Ernexa Therapeutics (ERNA) United States $0.007B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.006B 0.00
XTL Biopharmaceuticals (XTLB) Israel $0.006B 0.00
Heatwurx (PCSA) United States $0.005B 0.00
Salarius Pharmaceuticals (SLRX) United States $0.005B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.005B 0.00
Liminatus Pharma (LIMN) United States $0.005B 0.00
Aptorum Group (APM) United Kingdom $0.004B 0.00
InMed Pharmaceuticals (INM) Canada $0.004B 0.00
Niki BioSolutions (NIKI) United Kingdom $0.004B 0.00
Nuvilex (PMCB) United States $0.004B 0.00
Addex Therapeutics (ADXN) Switzerland $0.004B 0.00
Galmed Pharmaceuticals (EOCN) Israel $0.004B 0.00
Alaunos Therapeutics (TCRT) United States $0.004B 0.00
Redhill Biopharma (RDHL) Israel $0.004B 0.00
XORTX Therapeutics (XRTX) Canada $0.003B 0.00
60 Degrees Pharmaceuticals (SXTP) United States $0.003B 0.00
Jupiter Neurosciences (JUNS) United States $0.003B 0.00
SciSparc (SPRC) Israel $0.003B 0.00
Vivos Therapeutics (VVOS) United States $0.002B 0.00
Shuttle Pharmaceuticals Holdings (SHPH) United States $0.002B 0.00
Jaguar Animal Health (JAGX) United States $0.001B 0.00
China SXT Pharmaceuticals (SXTC) China $0.001B 0.00
Clearmind Medicine (CMND) Canada $0.001B 0.00
PainReform (PRFX) Israel $0.001B 0.00
CDT Equity (CDT) United States $0.000B 0.00
Emisphere Technologies (EMIS) United States $0.000B 0.00
4D Pharma (LBPS) United Kingdom $0.000B 0.00
Patheon (PTHN) Netherlands $0.000B 0.00
RVL Pharmaceuticals (RVLP) United States $0.000B 0.00